Metrics to compare | SILV | Peers Peers - average of corresponding metrics from companies closely matching SILV: CENTRALPHL, SILCOPHL, ORIONPHARM, IBP, TECHNODRUG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSILVPeersSector |
|---|---|---|---|---|
P/E Ratio | −8.4x | 14.1x | −0.3x | |
PEG Ratio | 0.49 | 0.05 | 0.00 | |
Price/Book | 0.6x | 1.3x | 2.6x | |
Price / LTM Sales | 3.9x | 2.3x | 2.9x | |
Upside (Analyst Target) | - | 36.3% | 65.2% | |
Fair Value Upside | Unlock | 10.6% | 9.1% | Unlock |
Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as anemias and other blood disorders, central nervous system, gastro- intestinal system, nutrition, anti-infectives, disinfectant, musculoskeletal and joint disease, respiratory system, cardiovascular system, endocrine system, and natural sweeteners. The company was incorporated in 2001 and is headquartered in Dhaka, Bangladesh.